Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
101.41
-1.80 (-1.74%)
At close: Nov 16, 2026, 4:00 PM EST
99.50
-1.91 (-1.88%)
After-hours: Nov 16, 2026, 7:37 PM EST

Zimmer Biomet Holdings Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
8,5708,2327,6797,3946,9406,827
Revenue Growth
6.98%7.20%3.85%6.55%1.65%11.42%
Gross Profit
5,9425,7385,4995,3194,9204,867
Operating Income
1,4351,4021,5941,5051,2861,222
Net Income
767.4705.1903.81,024231.4401.6
Earnings Per Share
3.953.554.434.881.101.91
EPS Growth
-2.00%-19.86%-9.22%343.48%-42.50%-

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Knees Net Sales
3,3363,3223,1743,0382,7782,648
Hips Net Sales
2,1792,0941,9991,9671,8951,856
S.E.T. Net Sales
2,3142,1501,8661,7531,6971,728
Technology & Data, Bone Cement and Surgical Net Sales
741.6665.6640.3636570595.5
Revenue (Total)
8,5708,2327,6797,3946,9406,827

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
426.9620.9527.1415.8382.5394.4
Total Debt
7,6577,8746,6216,2086,1387,314
Net Cash (Debt)
-7,230-7,253-6,094-5,792-5,756-6,920
Net Cash Growth
------
Net Cash Per Share
-37.17-36.50-29.89-27.62-27.37-32.89

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,8851,6971,4991,5821,2851,499
Capital Expenditures
-589.8-525-444.1-602.8-446.2-417.2
Free Cash Flow
1,2951,1721,055978.8838.51,082
Free Cash Flow Growth
7.30%11.07%7.82%16.73%-22.50%29.80%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
69.33%69.71%71.61%71.93%70.90%71.29%
Operating Margin
16.74%17.03%20.76%20.36%18.53%17.90%
Pretax Margin
10.32%10.09%13.50%14.43%5.81%7.31%
Profit Margin
8.95%8.57%11.77%13.85%3.33%5.88%
FCF Margin
15.11%14.24%13.74%13.24%12.08%15.85%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.9600.9600.9600.9600.9600.960
Dividend Per Share Growth
0%0%0%0%0%0%
Dividend Yield
0.95%1.05%0.91%0.78%0.75%0.76%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
25.6625.2823.2624.84115.6366.08
Forward PE
11.5010.7212.5215.4718.6316.40
P/FCF Ratio
14.8215.2119.9225.9831.9124.53
PS Ratio
2.242.172.743.443.863.89